| Description | This is a humanized antibody that demonstrates binding affinity to human ephrin-A4. Moreover, it exhibits cross-reactivity with mouse ephrin-A4 and cynomolgus ephrin-A4. The specific binding to human ephrin-A4 is characterized by an affinity of 4.8 nM. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human, Mouse, Cynomolgus |
| Affinity | KD = 4.8 nM |
| Isotype | Human IgG1 |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | ELISA |
| Application Notes | ELISA: 0.5 μg/mL |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | EFNA4 |
| Alternative Name | Ephrin A4; Ephrin-A4; LERK-4; EPLG4; LERK4; Eph-Related Receptor Tyrosine Kinase Ligand 4; EPH-Related Receptor Tyrosine Kinase Ligand 4; Ligand Of Eph-Related Kinase 4; EFL4 |
| Gene ID | 1945 |
| UniProt | P52798 |
| Related pathway | EPH-Ephrin signaling and Nervous system development |
| Research Area | Neuroscience |
| Related Disease | Craniofrontonasal Syndrome and Craniosynostosis |
